HomePGEN • NASDAQ
add
Precigen Inc
Previous close
$4.14
Day range
$3.77 - $4.14
Year range
$0.65 - $5.23
Market cap
1.13B USD
Avg Volume
13.42M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 856.00K | 19.39% |
Operating expense | 27.16M | 8.29% |
Net income | -26.64M | 54.68% |
Net profit margin | -3.11K | 62.04% |
Earnings per share | -0.08 | 23.22% |
EBITDA | -27.23M | -10.23% |
Effective tax rate | -0.01% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 59.75M | 205.86% |
Total assets | 101.90M | 39.28% |
Total liabilities | 107.79M | 259.43% |
Total equity | -5.90M | — |
Shares outstanding | 297.97M | — |
Price to book | -34.50 | — |
Return on assets | -60.38% | — |
Return on capital | -691.86% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -26.64M | 54.68% |
Cash from operations | -18.98M | 17.87% |
Cash from investing | 28.44M | 90.18% |
Cash from financing | -1.77M | -3,496.15% |
Net change in cash | 7.70M | 194.68% |
Free cash flow | -15.55M | 23.39% |
About
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
Founded
May 21, 1998
Website
Employees
143
